How do I buy Sangamo Therapeutics (SGMO) stock?

You can purchase shares of Sangamo Therapeutics (NASDAQ:SGMO) through any online brokerage.View our list of the best stock brokerages

Who are Sangamo Therapeutics (SGMO) competitors?

Other companies in Sangamo Therapeutics’s space includes: Molecular Partners AG (NASDAQ:MOLN), Kalaris Therapeutics Inc (NASDAQ:KLRS), Innate Pharma SA (NASDAQ:IPHA), ProQR Therapeutics NV (NASDAQ:PRQR) and Agenus Inc (NASDAQ:AGEN).

What is the forecast, or price target, for Sangamo Therapeutics (SGMO) stock?

Sangamo Therapeutics has a consensus price target of $4.85.

What is the current price for Sangamo Therapeutics (SGMO)?

The stock price for Sangamo Therapeutics (NASDAQ: SGMO) is $0.449 last updated January 12, 2026 at 7:59 PM EST.

Does Sangamo Therapeutics (SGMO) pay a dividend?

There are no upcoming dividends for Sangamo Therapeutics.

When is Sangamo Therapeutics (NASDAQ:SGMO) reporting earnings?

Sangamo Therapeutics does not have any upcoming earnings scheduled.

Is Sangamo Therapeutics (SGMO) going to split?

There is no upcoming split for Sangamo Therapeutics.

What sector and industry does Sangamo Therapeutics (SGMO) operate in?

Sangamo Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Sangamo Therapeutics (SGMO) Stock Price, Quote, News & History

Bulls vs Bears

Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Name

Revenue

Change

Gross

Change

EBITDA

Change

EBIT

Change

Earnings

Change

About

Sector

Health Care

Industry

Biotechnology

Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the P...

Comments